Effects of angiogenic factors, antagonists, and podocyte injury on development of proteinuria in preeclampsia

Reproductive Sciences

Volumn 20, Issue 5, 2013, Pages 579-588

  Chen, Guixiang ^a,b   Zhang, Lihong ^a   Jin, Xiaohong ^a   Zhou, Yunjiao ^a   Niu, Jianying ^a   Chen, Jing ^c   Gu, Yong ^a,c  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

angiogenic factors; podocyte; preeclampsia; proteinuria

Indexed keywords

ALBUMIN; CD135 ANTIGEN; CREATININE; PLACENTAL GROWTH FACTOR; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; KIDNEY INJURY; MATERNAL HYPERTENSION; MICROALBUMINURIA; PODOCYTE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; URINARY EXCRETION;

ADULT; ANALYSIS OF VARIANCE; ANGIOGENIC PROTEINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CREATININE; FEMALE; HUMANS; PODOCYTES; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY PROTEINS; PROTEINURIA; RISK FACTORS; ROC CURVE; URINALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 84876705177     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719112459227     Document Type: Article

References (36)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005 ; 365 (9461). 785-799
2. Collino F, Bussolati B, Gerbaudo E, et al. Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol. 2008 ; 294 (5). F1185 - F1194
3. Garovic VD, Wagner SJ, Petrovic LM, et al. Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant. 2007 ; 22 (4). 1136-1143
4. Achenbach J, Mengel M, Tossidou I, et al. Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases. Nephrol Dial Transplant. 2008 ; 23 (10). 3138-3145
5. Petermann A, Floege J. Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity. Nephron Clin Pract. 2007 ; 106 (2). c61 - c66
6. Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, Floege J. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol. 2005 ; 16 (6). 1733-1741
7. Hara M, Yanagihara T, Kihara I, Higashi K, Fujimoto K, Kajita T. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury. J Am Soc Nephrol. 2005 ; 16 (2). 408-416
8. Skoberne A, Konieczny A, Schiffer M. Glomerular epithelial cells in the urine: what has to be done to make them worthwhile?. Am J Physiol Renal Physiol. 2009 ; 296 (2). F230 - F241
9. Garovic VD, Wagner SJ, Turner ST, et al. Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol. 2007 ; 196 (4). e1-320
10. Aita K, Etoh M, Hamada H, et al. Acute and transient podocyte loss and proteinuria in preeclampsia. Nephron Clin Pract. 2009 ; 112 (2). c65 - c70
11. Karumanchi SA, Lindheimer MD. Preeclampsia and the kidney: footprints in the urine. Am J Obstet Gynecol. 2007 ; 196 (4). 287-288
12. Roberts L, LaMarca BB, Fournier L, Bain J, Cockrell K, Granger JP. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension. 2006 ; 47 (3). 615-618
13. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006 ; 355 (10). 992-1005
14. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004 ; 350 (7). 672-683
15. Levine RJ, Thadhani R, Qian C, et al. Urinary placental growth factor and risk of preeclampsia. JAMA. 2005 ; 293 (1). 77-85
16. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000 ; 183 (1). S1 - S22
17. Nakamura T, Ushiyama C, Hirokawa K, et al. Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis. Nephrol Dial Transplant. 2002 ; 17 (5). 798-802
18. Hara M, Yanagihara T, Kihara I. Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schonlein-Henoch purpura nephritis. Clin J Am Soc Nephrol. 2007 ; 2 (2). 231-238
19. Shah DM. Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am J Physiol Renal Physiol. 2005 ; 288 (4). F614-625
20. Strevens H, Wide-Swensson D, Hansen A, et al. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG. 2003 ; 110 (9). 831-836
21. Lemley KV, Lafayette RA, Safai M, et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int. 2002 ; 61 (4). 1475-1485
22. Nakamura T, Kawagoe Y, Ogawa H, et al. Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy. Am J Kidney Dis. 2005 ; 45 (1). 48-53
23. Harper SJ, Xing CY, Whittle C, et al. Expression of neuropilin-1 by human glomerular epithelial cells in vitro and in vivo. Clin Sci (Lond). 2001 ; 101 (4). 439-446
24. Sugimoto H, Hamano Y, Charytan D, et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem. 2003 ; 278 (15). 12605-12608
25. Thadhani R, Mutter WP, Wolf M, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab. 2004 ; 89 (2). 770-775
26. Lam C, Lim KH, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension. 2005 ; 46 (5). 1077-1085
27. Berkane N, Lefevre G, Hertig A. Angiogenic factors in preeclampsia: so complex, so simple?. Nephrol Dial Transplant. 2007 ; 22 (10). 2753-2756
28. Hawfield A, Freedman BI. Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection. Ther Adv Cardiovasc Dis. 2009 ; 3 (1). 65-73
29. Baker PN, Krasnow J, Roberts JM, Yeo KT.. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol. 1995 ; 86 (5). 815-821
30. Hunter A, Aitkenhead M, Caldwell C, McCracken G, Wilson D, McClure N. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension. 2000 ; 36 (6). 965-969
31. Bosio PM, Wheeler T, Anthony F, Conroy R, O'Herlihy C, McKenna P. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. Am J Obstet Gynecol. 2001 ; 184 (2). 146-152
32. Munaut C, Lorquet S, Pequeux C, et al. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Hum Reprod. 2008 ; 23 (6). 1407-1415
33. Akercan F, Cirpan T, Terek MC, et al. The immunohistochemical evaluation of VEGF in placenta biopsies of pregnancies complicated by preeclampsia. Arch Gynecol Obstet. 2008 ; 277 (2). 109-114
34. Sheppard SJ., Khalil RA. Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy. Cardiovasc Hematol Disord Drug Targets. 2010 ; 10 (1). 33-52
35. Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol. 2007 ; 2 (3). 543-549
36. Troisi R, Braekke K, Harsem NK, Hyer M, Hoover RN, Staff AC.. Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies. Am J Obstet Gynecol. 2008 ; 199 ( 6 ):